SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-16-010582
Filing Date
2016-02-03
Accepted
2016-02-03 16:19:30
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13G sc13g0216a1alpha_mabvax.htm SC 13G/A 28582
  Complete submission text file 0001213900-16-010582.txt   30281
Mailing Address 11588 SORRENTO VALLEY ROAD SUITE 20 SAN DIEGO CA 92121
Business Address 11588 SORRENTO VALLEY ROAD SUITE 20 SAN DIEGO CA 92121 8582599405
MABVAX THERAPEUTICS HOLDINGS, INC. (Subject) CIK: 0001109196 (see all company filings)

IRS No.: 930987903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-60385 | Film No.: 161385106
SIC: 2834 Pharmaceutical Preparations

Mailing Address PRADAFAUT 7 FURSTENTUMS 1490 VADUZ LIECHTENSTEIN C4 99999
Business Address PRADAFAUT 7 FURSTENTUMS 1490 VADUZ LIECHTENSTEIN C4 99999 0114232376363
ALPHA CAPITAL ANSTALT (Filed by) CIK: 0001140358 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A